|
Heart Failure
Technologies, Inc. (HFT) is a Minnesota based developmental stage
biopharmaceutical company. Founded by some of the countries foremost experts on
heart failure, HFT has developed a novel product and therapy called A.M.R.I.T.
(Advanced Myocardial Revitalization Therapy). A.M.R.I.T. has been designed to
significantly prolong survival and alleviate symptoms for heart failure
patients. A.M.R.I.T. is slated to be clinically and commercially applicable for
the 5 million heart failure patients in the United States and the 22 million
heart failure patients worldwide.
BioDrain Medical was formed in 2002 to create competitively priced,
environmentally safe systems for the collection and disposal of bio-hazardous
fluids that result from surgical procedures and post-operative care. The
founders include the product co-inventors Jeffrey Drogue and Jay Nord and the
management team that consists of Mr. Nord, Lawrence Gadbaw, President & CEO,
Gerald Rice, CFO & Secretary and Peter Morawetz, Board Member. BMI is in a
start-up mode employing Mr. Gadbaw and Mr. Rice and has completed no sales to
date. BMI provides the operating room (OR) with a faster, cleaner, safer
and less costly method of disposing blood, saline and other body fluids during
surgical procedures. The process is less intrusive because it eliminates the
fluid collection canister currently used by practically all hospitals and day
surgery centers. Existing products expose healthcare workers to blood-borne
diseases because they require more handling and fluid transfer and are more
costly because they utilize canisters that must be inventoried, set up, taken
down and disposed of. The Company has completed development work on its Fluid
Management System (FMS) and has obtained UL approval. Product demonstrations
commenced in January 2005 with favorable responses from OR and other hospital
personnel. BMI has set up a manufacturer in Grantsburg, Wisconsin and a sales
office in the same city. The Company is also in the process of setting up a
network of hospital distributors in the U.S. that will sell the FMS. BMI has
established a distributor in the UK and is developing contacts for China, Korea,
Australia, Canada, Mexico and the Middle East.
Lynne Osterman is a lobbyist
at Gray Plant Mooty. She represents clients on a variety of issues at the
legislature, including: bioscience, commerce, transportation, and health and
human services. Previously, Lynne served as a member of the Minnesota
House of Representatives. She worked on various Jobs & Economic Development
committees, the Workforce Development Taskforce of the Minnesota Bioscience
Council, the Governor’s Workforce Development Council, and the Minnesota Council
on Black Minnesotans. She successfully carried and promoted as chief house
author Governor Tim Pawlenty’s 2003 legislation to create the Bioscience Zone
and continues to work closely with Minneapolis, St. Paul, Rochester and other
communities and organizations to enhance Minnesota’s ability to grow the
bioscience industry. Lynne earned her Bachelor of Science in
Speech/Communications from St. Cloud State University in 1986. Lynne graduated
from the Institute for Organizational Management in 1996.
|